Aditxt Inc Stock Today
| ADTX Stock | USD 0.35 0.02 6.06% |
Performance0 of 100
| Odds Of DistressOver 81
|
Aditxt is trading at 0.35 as of the 28th of November 2024; that is 6.06% up since the beginning of the trading day. The stock's open price was 0.33. Aditxt has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Aditxt Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 30th of June 2020 | Category Healthcare | Classification Health Care |
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Aditxt operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 14.23 M outstanding shares of which 910.84 K shares are presently shorted by private and institutional investors with about 0.16 trading days to cover. More on Aditxt Inc
Moving together with Aditxt Stock
| 0.95 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.65 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.77 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.77 | INKT | Mink Therapeutics | PairCorr |
Moving against Aditxt Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aditxt Stock Highlights
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAditxt can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aditxt's financial leverage. It provides some insight into what part of Aditxt's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aditxt Inc (ADTX) is traded on NASDAQ Exchange in USA. It is located in 737 North Fifth Street, Richmond, VA, United States, 23219 and employs 47 people. Aditxt is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.7 M. Aditxt Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 14.23 M outstanding shares of which 910.84 K shares are presently shorted by private and institutional investors with about 0.16 trading days to cover.
Aditxt Inc currently holds about 803.97 K in cash with (18.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Aditxt Probability Of Bankruptcy
Ownership AllocationAlmost 99.74 percent of Aditxt outstanding shares are held by general public with 0.01 (percent) owned by insiders and only 0.25 % by other corporate entities.
Check Aditxt Ownership Details
Aditxt Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Two Sigma Investments Llc | 2024-09-30 | 32 K | |
| Fmr Inc | 2024-06-30 | 0.0 | |
| Geode Capital Management, Llc | 2024-09-30 | 17.7 K | |
| Tower Research Capital Llc | 2024-06-30 | 4.4 K | |
| Group One Trading, Lp | 2024-06-30 | 603 | |
| Ifp Advisors, Llc | 2024-06-30 | 503 | |
| Advisor Group Holdings, Inc. | 2024-06-30 | 101 | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 37.0 | |
| Bank Of America Corp | 2024-06-30 | 13.0 | |
| Ubs Group Ag | 2024-06-30 | 5.0 | |
| Wells Fargo & Co | 2024-06-30 | 0.0 |
Aditxt Historical Income Statement
Aditxt Stock Against Markets
Aditxt Corporate Management
| CPA CPA | President | Profile | |
| Thomas CPA | Chief Officer | Profile | |
| Matthew Shatzkes | Chief Counsel | Profile | |
| MS MD | Senior Discovery | Profile | |
| Dr D | Senior Transplantation | Profile | |
| Amro Albanna | Chairman CoFounder | Profile |
Already Invested in Aditxt Inc?
The danger of trading Aditxt Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aditxt is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aditxt. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aditxt Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Aditxt Stock Analysis
When running Aditxt's price analysis, check to measure Aditxt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aditxt is operating at the current time. Most of Aditxt's value examination focuses on studying past and present price action to predict the probability of Aditxt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aditxt's price. Additionally, you may evaluate how the addition of Aditxt to your portfolios can decrease your overall portfolio volatility.